Accueil   Diary - News   All news GeNeuro and Servier announce successful 12-month results

GeNeuro and Servier announce successful 12-month results

GeNeuro and Servier announce successful 12-month results in neuroprotection for Phase 2b CHANGE-MS Study with GNbAC1 in Multiple Sclerosis

 

  • Positive results on key endpoints related to neuroprotection
  • Safety of GNbAC1 confirmed
  • GeNeuro will hold a conference call and webcast today Monday, March 26th at 2:00 pm CEST / 8:00 am EDST, to discuss results

 

Read the press release